JOINT FILING AGREEMENTJoint Filing Agreement • February 2nd, 2001 • Capital Ventures International /E9/ • Electronic components, nec
The undersigned hereby agrees that the statement on Schedule 13G with respect to the shares of Common Stock of Microvision, Inc. dated February 1, 2000, and any amendments thereto signed by each of the undersigned shall be filed on behalf of each of them pursuant to and in accordance with the provisions of 13(d)-1(k) under the Securities Exchange Act of 1934.
EXHIBIT A LIMITED POWER OF ATTORNEY THIS LIMITED POWER OF ATTORNEY given on the 3rd day of April, 1998 by CAPITAL VENTURES INTERNATIONAL (hereinafter called "the Company"), whose Registered Office is situated at Second Floor, One Capital Place, P.O....Limited Power of Attorney • February 11th, 2000 • Capital Ventures International /E9/ • Electronic components, nec
THIS LIMITED POWER OF ATTORNEY given on the 3rd day of April, 1998 by CAPITAL VENTURES INTERNATIONAL (hereinafter called "the Company"), whose Registered Office is situated at Second Floor, One Capital Place, P.O. Box 1787, Grand Cayman, Cayman Islands, B.W.I.
LIMITED POWER OF ATTORNEYLimited Power of Attorney • August 12th, 2005 • Capital Ventures International /E9/ • Computer peripheral equipment, nec
THIS LIMITED POWER OF ATTORNEY given on the 3rd day of April, 1998 by Capital Ventures International (hereinafter called “the Company”), whose Registered Office is situated at Second Floor, One Capital Place, P.O. Box 1781, Grand Cayman Islands, B.W.I.
JOINT FILING AGREEMENTJoint Filing Agreement • April 30th, 2010 • Capital Ventures International /E9/ • Pharmaceutical preparations
This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Shares is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • April 10th, 2020 • Capital Ventures International • Services-prepackaged software
This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the ordinary shares of SINA Corporation, $0.133 par value per share, is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
LIMITED POWER OF ATTORNEYLimited Power of Attorney • June 9th, 2006 • Capital Ventures International /E9/ • Medicinal chemicals & botanical products
THIS LIMITED POWER OF ATTORNEY given on the 3rd day of April, 1999 by Capital Ventures International (hereinafter called “the Company”), whose Registered Office is situated at Second Floor, One Capital Place, P.O. Box 1781, Grand Cayman Islands, B.W.I.
Joint Filing AgreementJoint Filing Agreement • August 12th, 2005 • Capital Ventures International /E9/ • Computer peripheral equipment, nec
The undersigned hereby agrees that the statement on Schedule 13G with respect to the shares of Class A Common Stock of Wave Systems Corp., dated August 12, 2005, and any amendments thereto signed by each of the undersigned shall be filed on behalf of each of them pursuant to and in accordance with the provisions of 13(d)-1(k) under the Securities Exchange Act of 1934.
JOINT FILING AGREEMENTJoint Filing Agreement • June 9th, 2006 • Capital Ventures International /E9/ • Medicinal chemicals & botanical products
The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of Common Stock of Tapestry Pharmaceuticals, Inc., dated June 9, 2006, and any amendments thereto signed by each of the undersigned shall be filed on behalf of each of them pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934.
Exhibit II JOINT FILING AGREEMENTJoint Filing Agreement • March 21st, 2024 • Capital Ventures International • Search, detection, navagation, guidance, aeronautical sys
This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the shares of common stock of NextNav Inc., par value $0.0001 per share, is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
